(Q37704863)

22 August 2017

1 reference

title

Neuroethical issues in cognitive enhancement (English)

1 reference

22 August 2017

1 reference

1

1 reference

22 August 2017

2

Sharon Morein-Zamir

1 reference

22 August 2017

language of work or name

English

0 references

publication date

8 March 2010

1 reference

Journal of Psychopharmacology

22 August 2017

published in

1 reference

22 August 2017

volume

25

1 reference

22 August 2017

issue

2

1 reference

22 August 2017

page(s)

197-204

1 reference

Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans.

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Access to essential medicines: a Hobbesian social contract approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

The mental wealth of nations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Coming to terms with the nonmedical use of prescription medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Neurochemical modulation of response inhibition and probabilistic learning in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Cosmetic neurology: the controversy over enhancing movement, mentation, and mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Chemistry of the adaptive mind

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Cognitive impairment as a target for pharmacological treatment in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Neuroethics: the practical and the philosophical

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Neurocognitive enhancement: what can we do and what should we do?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Towards responsible use of cognitive-enhancing drugs by the healthy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Experts weigh in on promotion, prescription of off-label drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Be smart, exercise your heart: exercise effects on brain and cognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

AMPA receptor modulators as cognitive enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Selective alpha7 nicotinic acetylcholine receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Misperceptions of non-medical prescription drug use: a web survey of college students.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Sources of prescription drugs for illicit use

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Trends in non-medical use of anabolic steroids by U.S. college students: results from four national surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Selection and socialization effects of fraternities and sororities on US college student substance use: a multi-cohort national longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Characteristic neurocognitive profile associated with adult attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Methylphenidate improves working memory and set-shifting in AD/HD: relationships to baseline memory capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Modafinil: a review of neurochemical actions and effects on cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Modafinil shifts human locus coeruleus to low-tonic, high-phasic activity during functional MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Planning and spatial working memory following frontal lobe lesions in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Double dissociations of memory and executive functions in working memory tasks following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

The economic impact of attention-deficit/hyperactivity disorder in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Off-label prescribing among office-based physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Adrenergic pharmacology and cognition: focus on the prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Association of a functional polymorphism in the serotonin transporter gene with abnormal emotional processing in ecstasy users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Professor's little helper

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Neuroscientists need neuroethics teaching.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Methylphenidate and cognitive flexibility: dissociated dose effects in hyperactive children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Cognitive enhancing effects of modafinil in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Long-term effects of cognitive training on everyday functional outcomes in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Treatment, enhancement, and the ethics of neurotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

The Economic Burden of Schizophrenia in the United States in 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Off-label psychopharmacologic prescribing for children: history supports close clinical monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Effects of Stimulant Medication on Growth Rates Across 3 Years in the MTA Follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

Poll results: look who's doping

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881109106926

21 January 2018

Identifiers

DOI

10.1177/0269881109106926

1 reference

22 August 2017

1 reference